Markets

Updated Research Report on Deutsche Bank - Analyst Blog

On Apr 1, 2014, we issued an updated research report on Deutsche Bank AG ( DB ). We remain cautious over the company's growth prospects owing to several issues it is currently encountering.

Deutsche Bank's legal hassles have been a drag on its earnings. The mounting litigation costs pushed the company to record net loss of €965 million ($1.3 billion) in fourth-quarter 2013. Recently, a new probe related to bond dealings has been initiated by the Securities and Exchange Commission (SEC), which may further add to its legal woes.

Moreover, volatile market trends, macro economic headwinds and the prevalent stringent regulatory landscape have limited growth for Deutsche Bank. Notably, the company witnessed a year-over-year decline in revenues of 5% in 2013, reversing the past track record of revenue uptick at a CAGR of 19.9% over 5 years (2008-2012).

Weak fundamentals and dismal results at Deutsche Bank triggered a downward revision in the Zacks Consensus Estimate, as analysts turned more bearish on the stock's future performance. This is evident from the movement in the Zacks Consensus Estimate over the past 60 days. For 2014, it decreased 9.4% to $5.60 while it declined 2.2% to $7.47 per share for 2015.

Deutsche Bank currently carries a Zacks Rank #5 (Strong Sell).

Key Picks from the Sector

Some top-ranked stocks in the foreign banks space include Argentina based Banco Macro S.A. ( BMA ), Spanish bank Bankinter, S.A. ( BKNIY ) and France based Credit Agricole S.A. ( CRARY ). All these stocks carry a Zacks Rank #1 (Strong Buy).

BANKINTER SA (BKNIY): Get Free Report

BANCO MACRO-ADR (BMA): Free Stock Analysis Report

CREDIT AGRICOLE (CRARY): Get Free Report

DEUTSCHE BK AG (DB): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CRARY BKNIY DB BMA

Other Topics

Stocks

Latest Markets Videos